Aker Christopher Ray
- SEC CIK
- 0001762611
No open-market purchases or sales filed in the past year.
Current role at each company
- RGLS Regulus Therapeutics Inc.Sr. VP & General Counselas of Jun 27, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Aker Christopher Ray as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 18, 2024 (view filing) | Jan 18 | Same day | Aker Christopher RaySr. VP & General Counsel | SSale | −5.47K | $1.19 | −$6.51K | −35.2%10.1K after | |
| Jan 15, 2025 (view filing) | Jan 13-14 | 2 days | Aker Christopher RaySr. VP & General Counsel | SSale | −43.6K | $1.26 | −$55.0K | −46.8%49.5K after | 2 lots10b5-1 |